BZLF1 peptide vaccine (OSU-2131)

BZLF1 peptide vaccine · Ohio State University Comprehensive Cancer Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BZLF1 peptide vaccine (OSU-2131), covering 2026-04-21 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants [Phase 1]

See pricing